EB
Insider
Erin Burkhart
GVP, Chief Accounting OfficerErin Burkhart (GVP, Chief Accounting Officer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in BioMarin Pharmaceutical Inc. (BMRN). The largest single filing was $106K of BMRN (1,786 sh × $59.31, as filed), executed May 20 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$106K
shares × price, as filed
Last traded
May 20 2025
Filed May 20 2025
Median ADV $131.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $106K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
BMRNRecent filings
BMRNSALE
BioMarin Pharmaceutical Inc.
View filing →
$106K1,786 sh × $59.31
Exec May 20 2025
Filed May 20 2025 · 5:30 PM ET